These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11982703)
1. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies. Hazama H; Omagari K; Masuda J; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S J Gastroenterol Hepatol; 2002 Mar; 17(3):316-23. PubMed ID: 11982703 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929 [TBL] [Abstract][Full Text] [Related]
3. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis. Hazama H; Omagari K; Masuda J; Kinoshita H; Ohba K; Sakimura K; Matsuo I; Isomoto H; Murase K; Murata I; Kohno S J Clin Lab Anal; 2000; 14(5):208-13. PubMed ID: 11018798 [TBL] [Abstract][Full Text] [Related]
4. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis. Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to M2 mitochondrial autoantigens in normal human sera by immunofluorescence and novel assays. Omagari K; Rowley MJ; Whittingham S; Jois JA; Byron SL; Mackay IR J Gastroenterol Hepatol; 1996 Jul; 11(7):610-6. PubMed ID: 8840233 [TBL] [Abstract][Full Text] [Related]
7. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis. Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430 [TBL] [Abstract][Full Text] [Related]
9. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370 [TBL] [Abstract][Full Text] [Related]
10. Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein. Miyakawa H; Abe K; Kitazawa E; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Kako M Autoimmunity; 1999; 30(1):11-20. PubMed ID: 10433090 [TBL] [Abstract][Full Text] [Related]
11. Characterization of antimitochondrial antibodies in health adults. Mattalia A; Quaranta S; Leung PS; Bauducci M; Van de Water J; Calvo PL; Danielle F; Rizzetto M; Ansari A; Coppel RL; Rosina F; Gershwin ME Hepatology; 1998 Mar; 27(3):656-61. PubMed ID: 9500690 [TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. Ikuno N; Mackay IR; Jois J; Omagari K; Rowley MJ J Gastroenterol Hepatol; 2001 Dec; 16(12):1390-4. PubMed ID: 11851838 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723 [TBL] [Abstract][Full Text] [Related]
14. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. Kisand KE; Metsküla K; Kisand KV; Kivik T; Gershwin ME; Uibo R J Gastroenterol; 2001 Apr; 36(4):248-54. PubMed ID: 11324728 [TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495 [TBL] [Abstract][Full Text] [Related]
17. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects. Chen QY; Rowley MJ; Mackay IR Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459 [TBL] [Abstract][Full Text] [Related]
18. Enzyme inhibition assay for pyruvate dehydrogenase complex: clinical utility for the diagnosis of primary biliary cirrhosis. Omagari K; Hazama H; Kohno S World J Gastroenterol; 2005 Nov; 11(43):6735-9. PubMed ID: 16425376 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis. Kuroda M; Morito T; Takagi T; Ohira H; Kokubun M; Kojima T; Ono K; Kochi H; Kasukawa R J Hepatol; 1996 Dec; 25(6):867-76. PubMed ID: 9007715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]